Global Dry Eye Disease Market to Witness Increase in Revenues by 2025
 |
| Dry Eye Disease Market |
Dry
Eye Disease Market: Global Size, Trends, Competitive,
and Historical & Forecast Analysis, 2015-2025 – Increase
in geriatric population and various environmental factors are the key drivers
for Global Dry Eye Disease Market.
Dry eye disease market is
valued around USD 2796.8 Million in 2018 and expected to reach USD 3778.1
Million by 2025 with the CAGR of 4.7% over the forecast
period.
Dry eye disease is a disease caused due to the lack of tears or
lubrication in eyes which led to the burning sensation and redness in eyes.
These tears provide lubrication and each blink spread tears evenly and provide
nourishment to the eyes. When the production and drainage of tears are not
balanced then it leads to the dry eye disease. This condition is most common in
older population and there are various environmental conditions which are
responsible for such condition in young adults as well. The few symptoms
experienced by the people suffering from dry eye disease are irritation,
burning sensation, blurred vision and advanced stage may also lead to the
vision impairment. So, during the study of global dry eye disease market, we
have considered product type and distribution channel to analyze the market.
Global dry eye disease market report is segmented on the basis
of product type, distribution channel and by regional & country level.
Based upon product type, global dry eye disease market is classified as
artificial tears, anti-inflammatory drugs, punctal plugs, and secretagogue.
Based upon distribution channel, global dry eye disease market is classified as
hospital pharmacies, independent pharmacies and drug stores and online
pharmacies.
The regions covered in this dry eye disease market report are
North America, Europe, Asia-Pacific and Rest of the World. On the basis of
country level, market of Dry Eye Disease is sub divided into U.S., Mexico,
Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia,
GCC, Africa, etc.
Key Players for Global
Dry Eye Disease Market Reports–
Global dry eye disease market report covers prominent players
like Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Allergan plc,
Shire plc, TRB Chemedica International SA, Mitotech S.A., Sun Pharmaceutical
Industries Ltd., Senju Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd.,
Valeant Pharmaceuticals International, Inc., Otsuka Pharmaceutical Co., Ltd.,
Novartis AG, FCI S.A.S. and others.
Increase in geriatric
population and increasing approval for novel drugs
The commercialization and growth of global dry eye disease
market over the past 25 years has been highly impactful. One of the major
factors driving the growth of dry eye disease market over the forecast period
is increase in geriatric population. Due to the weakening of muscles and glands
in geriatric people, it is most common condition among them. As per
Population Reference Bureau report, the number of Americans aged 65 and older
are projected to more than double from 46 million today to over 98 million by
2060 and the 65-and-older age group’s share of the total population will rise
to nearly 24 percent from 15 percent. Moreover, there is a constant increase in
population and various other environmental factors which may affect the tear
production and led to the dry eye disease. Furthermore, there are various
research and development activities carried by major players which led to the
development of novel drugs and devices for the treatment of this condition.
Approval of such novel therapies is expected to foster the growth of dry eye
disease market. However, lack of prescription drugs are expected to inhibit the
growth of dry eye disease market over the forecast period.
North America is Expected
to Dominate the Dry Eye Disease Market
North America dominates the market with highest market share
over the forecast period due to the increased adoption of prescription drugs
for dry eye disease and increase in the approval of various new drugs developed
by the majr market players. Europe is expected to the second largest growing
region over the forecast period due to the technological advancements and
research and development activities which led to the development of new drugs
and devices. Asia Pacific is expected to be the third largest and fastest
growing region over the forecast period. Due to the increased awareness among
people, large patient pool, increase in healthcare facilities and increase in
per capita income are expected to promote the growth of dry eye disease market
over the forecast period. Latin America, Middle East and Africa are expected to
develop considerably over the forecast period.
Key Benefits for Global
Dry Eye Disease Market Reports –
·
Global market report covers in depth historical and forecast
analysis.
·
Global market research report provides detail information about
Market Introduction, Market Summary, Global market Revenue (Revenue USD),
Market Drivers, Market Restraints, Market opportunities, Competitive Analysis,
Regional and Country Level.
·
Global market report helps to identify opportunities in market
place.
·
Global market report covers extensive analysis of emerging
trends and competitive landscape.
Global
Dry Eye Disease Market Segmentation –
By Product Type analysis:
·
Artificial Tears
·
Anti-inflammatory Drugs
·
Punctal Plugs
·
Secretagogue
By Distribution Channel
Analysis
·
Hospital Pharmacies
·
Independent Pharmacies and Drug Stores
·
Online Pharmacies
By Regional & Country
Analysis
·
North America
·
U.S.
·
Canada
·
Europe
·
UK
·
France
·
Germany
·
Italy
·
Asia Pacific
·
China
·
Japan
·
India
·
Southeast Asia
·
Latin America
·
Brazil
·
Mexico
·
Middle East and Africa
·
GCC
·
Africa
·
Rest of Middle East and Africa
Comments
Post a Comment